Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Pharmacogenomics. 2011 Jul;12(7):1039–1050. doi: 10.2217/pgs.11.48

Table 1.

Brief overview of cisplatin-induced ototoxicity and genetic polymorphisms.

Author
(year)
Genetic polymorphisms
tested
Patients
(n)
Observation Hearing testing Ref.
Peters
et al.
(2000)
GSTM1, GSTM3, GSTT1,
GSTP1, GSTZ1
39 Protective effects of GSTM3*B (p = 0.023) Audiometry [60]
Oldenburg
et al.
(2007)
GSTT1, GSTM1, GSTP1 173 Protective effects of 105Val-GSTP1 (p < 0.001)
Detrimental effects of GSTM1 positivity
(p < 0.022)
Audiometry [53]
Oldenburg
et al.
(2007)
GSTT1, GSTM1, GSTP1 238 Protective effects of GSTP1G (p = 0.008)
Detrimental effects of GSTM1 (p = 0.025)
Self-reported
tinnitus
[64]
Barahmani
et al.
(2009)
GSTM1, GSTT1, GSTM1T1 34 No associations found Audiometry [51]
Riedemann
et al.
(2008)
Megalin, SNPs rs2075252,
rs4668123
50 Detrimental effects of A allele of rs2075252
(p < 0.02)
No association with SNP rs4668123
Audiometry [21]
Ross et al.
(2009)
Megalin, TPMT (rs1220119),
COMT (rs9332377), GSTP1
(rs1695G–G), GSTM1
166 Detrimental effects of TPMT (rs1220119);
(p = 0.00018) and COMT (rs9332377);
(p = 0.00109)
No association with megalin, GSTP1
(p = 0.61) or GSTM1 (p = 0.51)
Audiometry [14]
Peters
et al.
(2003)
Mitochondrial DNA mutations:
A7445G mut, 7472insC, A1555G
mut, nucleotide variations in
D-loop region, European
haplogroup J
39 Hearing loss more frequent in European
haplogroup J
Audiometry [70]
Knoll et al.
(2006)
GJB2, SLC26A4, mitochondrial
DNA mutations: A1555G,
A3243G, A7445G
11 No associations found Self-reported [71]
Caronia
et al.
(2009)
ERCC2, XPC, XPA
ERCC1, ERCC4, ERCC5
32 Detrimental effects of XPC Audiometry [72]

ins: Insertion; mut: Mutation; XPC: Xeroderma pigmentosum type C.